Pulmonary Hypertension PBMC

All filters

Format

Format

Format
Volume

Volume

Volume
Condition

Condition

Condition

Start typing to see matching condition.

Most stocked

Donor Demographics

Donor Demographics

Gender
Age
Race

Start typing to see matching race.

Country
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot # / SO#

Start typing to see matching Lot # / SO#.

Patient ID

Start typing to see matching Patient ID.

12 lots match
12 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Pulmonary Hypertension PBMC 80661 133832 Female 46-60 Caucasian Cryopreserved 1 mL 2 10M sildenafil 20 mg TIL pantoprazole 40 mg QD necardapine 40 mg BID Pentoxifylline 400 mg BID Baby aspirin 81 mg QD fish oil 1400 mg QD vit d3 5000 iu QD Co Q 10 200 mg QD Veg/Fruit Gummy BID Pulmonary Hypertension United States 2026 — — — — — — — — — 223911; 223910PBMC10M cellsPulmonary HypertensionPulmonary HypertensionYespenicillin25.12NoNoNoNoNoNONoStoredIn Stock
$765
Pulmonary Hypertension PBMC 73154 134319 Female 61+ Caucasian Cryopreserved 1 mL 1 10M Adempas 2.5mg TID Letairis 10mg QD Uppradi 1600mcg BID Omeprazole 20mg QD Rosuvastatin 10mg QD Cholestipol 2 1mg tablets QD Vitamin b12, D, calcium supplements Pulmonary Hypertension United States 2026 — — — — — — — — — 185828PBMC10M cellsPulmonary HypertensionPulmonary HypertensionYestree nuts26.17Non ReactiveYesNoNoNoYesNOYesStoredIn Stock
$765
Pulmonary Hypertension PBMC 69946 134478 Female 31-45 Hispanic/Latino Cryopreserved 1 mL 80 50M Orenitram 5mg Letairis 10 mg Adcirca 20 mg Pulmonary Hypertension United States 2025 A*01:01:01:01/A*24:02:01:01 — — — — — — — — 164643; 164644; 164645; 164646; 164647; 164648; 164649; 164650; 164651; 164652; 164653; 164654; 164655; 164656; 164583; 164584; 164585; 164586; 164587; 164588; 164589; 164590; 164591; 164592; 164593; 164594; 164595; 164596; 164597; 164598; 164599; 164600; 164601; 164602; 164603; 164604; 164605; 164606; 164607; 164608; 164609; 164610; 164611; 164612; 164613; 164614; 164615; 164616; 164617; 164618; 164619; 164620; 164621; 164622; 164577; 164578; 164579; 164580; 164581; 164582; 164623; 164624; 164625; 164626; 164627; 164628; 164629; 164630; 164631; 164632; 164633; 164634; 164635; 164636; 164637; 164638; 164639; 164640; 164641; 164642PBMC50M cellsPulmonary HypertensionPulmonary HypertensionNoIODINE24.03ReactiveYesNoNoNoYesNONoARH+StoredIn Stock
$1,208
Pulmonary Hypertension PBMC 69059 150183 Female 31-45 Hispanic/Latino Cryopreserved 1 mL 72 50M Orenitram 0.5 mg 3x/day Letairis 10 mg/1x day Winrevair 1mg/3 weeks, last injection 5/11 Bumex as needed Pulmonary Hypertension United States 2025 A*01:01:01:01/A*26:01:01:01 — — — — — — — — 155368; 155369; 155370; 155371; 155372; 155373; 155374; 155375; 155376; 155377; 155378; 155379; 155380; 155381; 155382; 155383; 155384; 155385; 155386; 155328; 155329; 155330; 155331; 155332; 155333; 155334; 155335; 155336; 155337; 155338; 155339; 155340; 155341; 155342; 155343; 155344; 155345; 155346; 155347; 155315; 155316; 155317; 155318; 155319; 155320; 155321; 155322; 155323; 155324; 155325; 155326; 155327; 155348; 155349; 155350; 155351; 155352; 155353; 155354; 155355; 155356; 155357; 155358; 155359; 155360; 155361; 155362; 155363; 155364; 155365; 155366; 155367PBMC50M cellsPulmonary HypertensionPulmonary HypertensionNoChlorahexadine31.24Non ReactiveYesNoNoNoNoNOYesABRH+StoredIn Stock
$1,208
Pulmonary Hypertension PBMC 69946 134478 Female 31-45 Hispanic/Latino Cryopreserved 1 mL 12 10M Orenitram 5mg Letairis 10 mg Adcirca 20 mg Pulmonary Hypertension United States 2025 A*01:01:01:01/A*24:02:01:01 — — — — — — — — 164657; 164658; 164659; 164660; 164661; 164662; 164663; 164664; 164665; 164666; 164667; 164668PBMC10M cellsPulmonary HypertensionPulmonary HypertensionNoIODINE24.03ReactiveYesNoNoNoYesNONoARH+StoredIn Stock
$765
Pulmonary Hypertension PBMC 66907 133850 Female 31-45 Hispanic/Latino Cryopreserved 1 mL 104 50M Letairis 10 mg 1x/day Adempas 2.5 mg 3x/day Winrevair 1.3 ml/ every 3 weeks, last injection Pulmonary Hypertension United States 2025 A*03:01:01:05/A*24:02:01:01 — — — — — — — — 144762; 144763; 144764; 144765; 144766; 144767; 144768; 144769; 144770; 144771; 144772; 144773; 144774; 144775; 144776; 144777; 144778; 144779; 144742; 144743; 144744; 144745; 144746; 144747; 144748; 144749; 144750; 144751; 144752; 144753; 144754; 144755; 144756; 144757; 144758; 144759; 144760; 144761; 144702; 144703; 144704; 144705; 144706; 144707; 144708; 144709; 144710; 144711; 144712; 144713; 144714; 144715; 144716; 144717; 144718; 144719; 144720; 144721; 144676; 144677; 144678; 144679; 144680; 144681; 144722; 144723; 144724; 144725; 144726; 144727; 144728; 144729; 144730; 144731; 144732; 144733; 144734; 144735; 144736; 144737; 144738; 144739; 144740; 144741; 144682; 144683; 144684; 144685; 144686; 144687; 144688; 144689; 144690; 144691; 144692; 144693; 144694; 144695; 144696; 144697; 144698; 144699; 144700; 144701PBMC50M cellsPulmonary HypertensionPulmonary HypertensionNo36.9ReactiveYesNoNoNoYesYESYesORH+StoredIn Stock
$1,208
Pulmonary Hypertension PBMC 68412 133754 Female 46-60 Asian/Pacific Islander Cryopreserved 1 mL 72 50M TYVASO - NEBULIZER BOSENTAN 125 MG- PAH BABY ASPRIN ALDATONE 5 MG MUTLTI VIT Pulmonary Hypertension United States 2025 A*03:01:01:01/A*30:01:01:01 — — — — — — — — 152355; 152356; 152357; 152358; 152359; 152360; 152361; 152362; 152363; 152364; 152365; 152366; 152367; 152368; 152369; 152370; 152371; 152372; 152373; 152374; 152341; 152342; 152343; 152344; 152345; 152346; 152347; 152348; 152349; 152350; 152351; 152352; 152353; 152354; 152375; 152376; 152377; 152378; 152379; 152380; 152381; 152382; 152383; 152384; 152385; 152386; 152387; 152388; 152389; 152390; 152391; 152392; 152393; 152394; 152395; 152396; 152397; 152398; 152399; 152400; 152401; 152402; 152403; 152404; 152405; 152406; 152407; 152408; 152409; 152410; 152411; 152412PBMC50M cellsPulmonary HypertensionPulmonary HypertensionNo23.17ReactiveYesNoNoNoYesNOYesORH+StoredIn Stock
$1,208
Pulmonary Hypertension PBMC 68412 133754 Female 46-60 Asian/Pacific Islander Cryopreserved 1 mL 12 10M TYVASO - NEBULIZER BOSENTAN 125 MG- PAH BABY ASPRIN ALDATONE 5 MG MUTLTI VIT Pulmonary Hypertension United States 2025 A*03:01:01:01/A*30:01:01:01 — — — — — — — — 152335; 152336; 152337; 152338; 152339; 152340; 152329; 152330; 152331; 152332; 152333; 152334PBMC10M cellsPulmonary HypertensionPulmonary HypertensionNo23.17ReactiveYesNoNoNoYesNOYesORH+StoredIn Stock
$765
Pulmonary Hypertension PBMC 66907 133850 Female 31-45 Hispanic/Latino Cryopreserved 1 mL 12 10M Letairis 10 mg 1x/day Adempas 2.5 mg 3x/day Winrevair 1.3 ml/ every 3 weeks, last injection Pulmonary Hypertension United States 2025 A*03:01:01:05/A*24:02:01:01 — — — — — — — — 144664; 144665; 144666; 144667; 144668; 144669; 144670; 144671; 144672; 144673; 144674; 144675PBMC10M cellsPulmonary HypertensionPulmonary HypertensionNo36.9ReactiveYesNoNoNoYesYESYesORH+StoredIn Stock
$765
Pulmonary Hypertension PBMC 69059 150183 Female 31-45 Hispanic/Latino Cryopreserved 1 mL 12 10M Orenitram 0.5 mg 3x/day Letairis 10 mg/1x day Winrevair 1mg/3 weeks, last injection 5/11 Bumex as needed Pulmonary Hypertension United States 2025 A*01:01:01:01/A*26:01:01:01 — — — — — — — — 155388; 155389; 155390; 155391; 155392; 155393; 155394; 155395; 155396; 155397; 155398; 155387PBMC10M cellsPulmonary HypertensionPulmonary HypertensionNoChlorahexadine31.24Non ReactiveYesNoNoNoNoNOYesABRH+StoredIn Stock
$765
Pulmonary Hypertension PBMC 59295 134393 Female 31-45 African American Cryopreserved 1 mL 4 5M Plaque-nil 200mg QD IViG Infusions every 3 weeks Lyrica 200mg QD OxyContin 20mg QD Oxycodone 10.325mg QD Pulmonary Hypertension United States 2024 — — — — — — — — — 54299; 54300; 54301; 54302PBMC5M cellsPulmonary HypertensionPulmonary HypertensionNo35.07NoNoNoNoNoNOYesStoredIn Stock
$765
Pulmonary Hypertension PBMC 55948 133900 Female 61+ Caucasian Cryopreserved 1 mL 2 9M Sildenafil 20mg TID lisinopril 5mg Hydroxychloroquine 200 mg BID pepcid Tylenol PRN O2 Pulmonary Hypertension United States 2024 — — — — — — — — — 41984; 41985PBMC9M cellsPulmonary HypertensionPulmonary HypertensionYeskeflex36.09NoNoNoNoNoNOYesStoredIn Stock
$765

Showing 1–12 of 12 lots

About Pulmonary Hypertension PBMC

Pulmonary Hypertension PBMC are sourced from consented donors with documented pulmonary hypertension. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Pulmonary Hypertension research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Pulmonary Hypertension
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Processing specifications

Anticoagulant
Confirmed per lot on request
Isolation
Density-gradient centrifugation (SepMate™); optional RBC lysis
Processing window
Processed within ~24 hours of collection unless otherwise stated
Cryopreservation
Cryopreservation medium with 10% DMSO; controlled-rate freezing (−1 °C/min)
Storage
Vapor-phase liquid nitrogen
Count and viability
Automated dual-fluorescence cell counter; cells per vial listed per lot
Aliquot sizes
5 × 10⁶ cells (vial)1 × 10⁷ cells (vial)5 × 10⁷ cells (vial)2 × 10⁹ cells (bulk vials)

From Sanguine's processing protocols. View protocols

Donor and clinical data in these lots

Fields recorded on the 12 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.

Donor

Sex
12 of 12 lots
Age
12 of 12 lots
Race
12 of 12 lots
BMI
12 of 12 lots

Clinical history

Primary diagnosis
12 of 12 lots
Current medications
12 of 12 lots
Allergies
12 of 12 lots
Infectious disease history
12 of 12 lots

Lab results & genotype

CMV serostatus
9 of 12 lots
ABO / Rh blood type
8 of 12 lots
HLA class I typing
8 of 12 lots

Lifestyle

Tobacco use
12 of 12 lots
Alcohol use
12 of 12 lots
Recreational drug use
12 of 12 lots
Caffeine use
12 of 12 lots

Collection

Collection date
12 of 12 lots
Country of collection
12 of 12 lots

Need a field that isn't listed, such as disease stage or time since diagnosis?

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Pulmonary Hypertension PBMC with normal donor samples for comparison

Healthy Donor PBMCs

733 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information